Policy & Medicine

Legal, Regulatory, and Compliance Issues

facebook
twitter
google_plus
Email

Browsing daily archive

November 14, 2017

Changes to 340B Program Reduces Hospital Reimbursement for Pharmaceutical Products by 28.5%

Open Payments
Litigation
FDA
CME
Opioids
International
State Policy
Transparency
COVID-19
CMS
MACRA

View Desktop Version